<DOC>
	<DOCNO>NCT01741142</DOCNO>
	<brief_summary>The purpose study efficacy safety ABT-436 Major Depressive Disorder .</brief_summary>
	<brief_title>Efficacy Safety Study ABT-436 Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Has primary Diagnostic Statistical Manual Mental DisordersFourth EditionText Revision diagnosis major depressive disorder without psychotic feature No current antidepressant treatment within 7 halflives 2 week , whichever longer , prior Day minus 1 . Can safely treated outpatient basis . A condition general good physical health . Surgically sterile , use highly effective method birth control ( female ) least 1 year post menopausal . History hypersensitivity , intolerance adverse reaction escitalopram lead discontinuation , hypersensitivity citalopram . History serotonin syndrome . Inadequate response two different antidepressant medication current major depressive episode . History electroconvulsive therapy , vagal nerve stimulation deep brain stimulation . History transcranial magnetic stimulation current major depressive episode . Psychotherapy ongoing least 3 month prior Day minus 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Major Depressive Disorder</keyword>
</DOC>